The Last 10 Years of Research in the Enantioseparation of Pharmacologically Relevant Phytocannabinoids: An Updated Review
Journal of Separation Science · 2025
DOI: 10.1002/jssc.70234 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Separation Science, 2025. Verfasst von Ina Varfaj und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy. Hauptthemen laut MEDLINE: Cannabinoids, Cannabis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
As research on Cannabis sativa L. and its derivatives expands, an increasing number of novel phytocannabinoids are being identified. Many of these compounds exhibit molecular chirality due to the presence of one or more stereogenic centers in their structures. Given the pharmacological and toxicological relevance of chiral molecules, regulatory authorities are expected to demand more stringent analytical characterization of the enantiomeric composition of phytocannabinoids in C. sativa L. extracts. The growing availability and enhanced performance of advanced analytical technologies, particularly chiral chromatographic systems, have renewed interest in the stereochemical profiling of these natural products. Chiral separation techniques have become central to research efforts aimed at determining enantiomeric purity and understanding stereoisomeric distributions in complex plant matrices. Among the limited studies addressing chiral chromatographic methods for separating phytocannabinoid enantiomers and diastereomers, two techniques are predominant: high‐performance liquid chromatography (HPLC) and supercritical fluid chromatography (SFC). Method development in both approaches typically relies on two major classes of chiral stationary phases (CSPs). The first comprises Pirkle‐type CSPs, which utilize the “Inverted Chirality Columns Approach” (ICCA) and are based on rational design principles for enantioselective interactions. The second group includes polysaccharide‐based CSPs employing cellulose or amylose derivatives, recognized for their broad applicability in resolving diverse phytocannabinoid enantiomers. This work will review a selection of recent, representative studies, highlighting key analytical strategies for chiral separation, methodological challenges, and implications for both scientific research and regulatory frameworks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
- Department of Pharmacy and Biotechnology (FaBiT), Alma Mater Studiorum-University of Bologna, Bologna, Italy.
- Department of Chemistry "U. Schiff,", University of Florence, Florence, Italy.
Zitieren
APA
Varfaj, I., Ianni, F., Abualzulof, G. W. A., Migni, A., Mercolini, L., Furlanetto, S., Carotti, A., & Sardella, R. (2025). The Last 10 Years of Research in the Enantioseparation of Pharmacologically Relevant Phytocannabinoids: An Updated Review. Journal of Separation Science. https://doi.org/10.1002/jssc.70234
Vancouver
Varfaj I, Ianni F, Abualzulof GWA, Migni A, Mercolini L, Furlanetto S, et al. The Last 10 Years of Research in the Enantioseparation of Pharmacologically Relevant Phytocannabinoids: An Updated Review. Journal of Separation Science. 2025. doi:10.1002/jssc.70234
BibTeX
@article{Varfaj2025,
author = {Varfaj, Ina and Ianni, Federica and Abualzulof, Ghaid W A and Migni, Anna and Mercolini, Laura and Furlanetto, Sandra and Carotti, Andrea and Sardella, Roccaldo},
title = {The Last 10 Years of Research in the Enantioseparation of Pharmacologically Relevant Phytocannabinoids: An Updated Review},
journal = {Journal of Separation Science},
year = {2025},
doi = {10.1002/jssc.70234}
}
EUVIMED